Abstract
749P - Prognostic and predictive factors from the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in previously treated advanced hepatocellular carcinoma (aHCC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have